Upcoming events – Karyopharm's myeloma expansion and Pfizer's biz dev news

Quote
cafead

cafead

Administrator
Staff member
  • cafead   Jan 05, 2020 at 07:22: PM
via Karyopharm hopes to move Xpovio earlier in the multiple myeloma treatment sequence, and data are due for Akcea/Ionis’s triglyceride regulator, for which Pfizer paid a hefty sum.

article source
 

<



Similar threads

cafead
Upcoming events – Fibroid data for Obseva, as Inventiva turns to Nash
Replies
0
Views
123
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
Upcoming events – Soleno has a date with Destiny while Arbutus tries again
Replies
0
Views
108
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
Upcoming events – Filgotinib&#039;s ulcerative colitis data and serlopitant takes on pruritus
Replies
0
Views
106
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
Upcoming events – Avadel takes on Jazz and Axovant awaits early results
Replies
0
Views
119
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
Upcoming events – Genmab&#039;s route to market, and late-stage data for Zogenix
Replies
0
Views
141
Pharma/Biotech Companies - In the News
cafead
cafead
Top Bottom
Back
Quote